Using Tide hasn't been shown to cause cancer.

1. Concern (minor) Rates the real claim

   Reword the claim to "Using Tide laundry detergent causes cancer" so it matches what the title, answer and editorial note actually rate.

   The claim field is the broad "Tide laundry detergent causes cancer." but the editorial note scopes the review to "whether ordinary use of Tide laundry detergent causes cancer", and the title and answer rate "Using Tide". Narrowing to use is how the claim mostly circulates, so the article is not rating a strawman, and it does discuss the downstream drinking-water pathway. But the gap matters here: the article's own EPA evidence finds that 1,4-dioxane in laundry detergents "significantly contributes to unreasonable risk" via drinking water, which supports the broad wording more than the narrowed one. A reader comparing the claim and the title sees two slightly different questions. Minor because a reader comes away with the same understanding once they read the answer.

   About conclusion The finding

2. Concern (material) Rating follows from the evidence

   Reconsider "No evidence": the article's evidence is affirmative both ways (EPA found no consumer-use risk but a detergent-linked drinking-water cancer risk), which fits "Misleading".

   Before reading the label, I would rate this from the evidence as Misleading, moderate confidence. The claim has a real kernel: the evidence says the byproduct is an animal carcinogen classified by IARC and NTP, and EPA's 2024 revision concluded that 1,4-dioxane "in products like dish soaps and laundry detergents significantly contributes to unreasonable risk" through drinking water. Its implied mechanism, that using Tide gives you cancer, is not supported: EPA "found that this use did not present an unreasonable risk to consumers". "No evidence" means the evidence is insufficient, yet the article presents substantial evidence on both sides: an exposure-based finding against consumer-use risk and an affirmative regulatory risk finding tied to detergents. The changelog says the label moved from "Mostly false" to "No evidence" "since no study links using Tide to cancer", which treats the absence of an epidemiological study as insufficiency even though EPA's exposure modelling is evidence. The objection response itself says the EPA point is "accurate, and it is the strongest version of the claim". A reader shown "No evidence" would believe nothing points toward the claim, which the article's own evidence:epa-risk-evaluation contradicts. A careful reviewer could defend "No evidence" only for a claim narrowed to personal use, hence Material rather than Fail.

   About conclusion, evidence:epa-risk-evaluation, evidence:hazard-classification The finding

3. Concern (minor) Strongest objections answered

   Explain why Tide still measured 6.1 to 14 ppm in 2019, six years after P&G's 2013 Prop 65 settlement to reformulate, so readers don't infer the settlement cut exposure.

   The objections section is strong. It answers the hazard-versus-risk objection, the strongest one (EPA links detergents to drinking-water cancer risk) with evidence, the European-ban rumour, the labelling objection, and the 'natural' detergent alternative. One alternative reading goes unanswered. The conclusion says "Exposure has also fallen" and lists the 2013 settlement "to reformulate below California's no-significant-risk level" first, yet evidence:product-testing reports 6.1 to 14 ppm in the same products in 2019. A skeptic could say the settlement achieved little and that only New York's law moved levels. The article does not say whether 6.1 to 14 ppm was consistent with the settlement's threshold (a dose-based level, not a concentration) or whether the settlement was met. A secondary gap, so Minor.

   About conclusion, evidence:legal-limits, evidence:product-testing The finding

4. Concern (minor) Evidence is independent

   Retitle the hazard item: IARC and NTP both rest on rodent drinking-water bioassays, so they are not two independent lines; and the use-risk finding rests on EPA alone.

   The hazard item is titled "Two independent cancer agencies classify 1,4-dioxane..." and method step 2 says the evidence is separated "so that no conclusion rests on a single category." Both classifications are described as resting on the same kind of evidence, animal drinking-water studies ("drinking-water exposure produced liver tumors in mice, rats and guinea pigs"), and the article does not show they rely on different bioassays. Two agencies reviewing a shared animal literature are not independent lines. Separately, the finding about personal use, the point the rating turns on, rests on EPA alone. hk-summary is a law-firm summary derived from the same EPA determination, and the limitation acknowledges single-agency dependence. Independent support remains (hazard, EPA, product testing and legal limits are distinct categories), so Minor.

   About evidence:hazard-classification, source:iarc-vol71, source:ntp-roc, evidence:epa-risk-evaluation, source:hk-summary The finding

5. Pass Confidence matches the evidence

   Confidence is Moderate, which fits evidence that rests on animal hazard data, one agency's exposure modelling (which the limitation acknowledges: "depends on a single agency's modeling, and EPA's conclusions changed between 2020 and 2024"), and an unreplicated advocacy-commissioned test. The title ("Using Tide hasn't been shown to cause cancer.") claims no more than the evidence supports. The conclusion lists what remains open: no epidemiology in detergent users, unreplicated testing, a pending EPA rule and litigation. I would also have chosen Moderate.

Coverage: Examined the full article payload: claim, finding, answer, confidence, title, summary, description, context, keyPoints, conclusion, all four evidence items with methods, institutions, years and limitations, all five objections, seven method steps, editorial note, changelog, and source names/titles. Source snapshots were not read, per the Skeptic's instructions; evidence was taken as stated.

1. Concern (minor) Title states the finding

   Lead with a positive finding, e.g. "EPA found no cancer risk from using Tide; its 1,4-dioxane concern is drinking water"; make seoTitle state the finding.

   Rule: state the verified finding in positive form, and use negative wording only when no accurate positive statement exists. The title "Using Tide hasn't been shown to cause cancer." names the subject and resolves the claim, and a No evidence finding permits negative wording. But an accurate positive statement exists in the article itself (EPA "did not present an unreasonable risk to consumers"), so the negation is avoidable. Rule: seoTitle may use search wording "as long as it states the finding". "Does Tide detergent cause cancer? The 1,4-dioxane evidence" poses the question without answering it. Both are Minor under the rule.

   About conclusion The finding

2. Concern (minor) Each section does its job

   Rewrite the summary to name the strongest evidence (EPA exposure reviews plus product testing), and add an independence note (countries, methods, decades) to the editorial note.

   Rule: the summary is one sentence naming the strongest independent lines of evidence. The summary ("Claims that Tide causes cancer trace back to 1,4-dioxane ... that IARC and the U.S. National Toxicology Program classify as a possible or anticipated human carcinogen based on animal studies") gives only background and the hazard classification. It omits the EPA exposure reviews, which carry the finding, so a reader who sees only the summary gets the claim's side. Rule: the article includes a brief independence note (how many countries, methods and decades). The editorial note covers scope, caveats and review status ("No external specialist review has been recorded") but has no independence note. The context and conclusion do their jobs: the conclusion synthesizes hazard against risk and states what remains unproven. Two Minor lapses in one check.

   About conclusion The finding

3. Concern (minor) Tone is measured and respectful

   Soften "confirms" in the product-testing summary and the labeling objection to "indicates", since the article itself says the 2024 test was not independently replicated.

   Rule: use measured language rather than absolutes the evidence does not justify. The product-testing summary says the drop "confirms that manufacturers can and did reduce the byproduct", and the labeling objection response says "The 2019 and 2024 tests confirm the byproduct was present and has since been reduced." The item's own limitation says the test was advocacy-commissioned, did not name the lab, and "We found no independent replication of the 2024 results", so "confirms" claims more than the article allows. Objections are otherwise answered respectfully and without ridicule. "There is no such ban" is backed by a cited fact-check.

   About evidence:product-testing, limitation:product-testing, conclusion The finding

4. Concern (minor) Consistent house style

   Describe IARC 2B as "possible" (not "likely") in the hazard title, spell out IARC, P&G and ppm at first use, explain surfactant/ethoxylation, and use one capitalization for No Significant Risk Level.

   Rule: names and terms used the same way throughout. The hazard evidence title says the agencies "classify 1,4-dioxane as a likely carcinogen", but the summary and key points say IARC rates it "possibly carcinogenic to humans (Group 2B)" and NTP says "reasonably anticipated". Rule: spell out abbreviations at first use. "IARC" first appears unexpanded in the summary. "P&G" first appears in the context and first key point, and "Procter & Gamble" is spelled out only later in evidence:legal-limits. "ppm" appears in key points before "part per million" is spelled out in evidence:product-testing. Rule: explain technical terms at first use. The context says 1,4-dioxane "forms ... when some surfactants are made by ethoxylation" without explaining either term. Rule: consistent names and capitalization. The term appears as "No Significant Risk Level" in evidence:legal-limits and "no-significant-risk level" in the conclusion. No typos or leftover drafting text found. All Minor.

   About evidence:hazard-classification, evidence:legal-limits, evidence:product-testing, conclusion The finding

5. Pass Verdict fields agree and stand alone

   Read alone: FactHub rates the claim "Tide laundry detergent causes cancer." No evidence (Moderate confidence): "Studies have not linked using Tide to cancer; the concern is a trace byproduct reaching drinking water." The claim reads naturally in quotation marks and is the claim, not its correction. The answer stands alone and says what is true. The title, answer and conclusion ("there is no evidence that using it does") agree with the No evidence label, and no stale "Mostly false" wording survives from the earlier label (the changelog notes the change).

6. Pass Limitations are specific

   Each limitation is specific to its item. Hazard: "hazard classifications ... not whether a given exposure ... does" and "The IARC evaluation dates from 1999". EPA: location-dependent drinking-water risk, pending litigation, reliance on a law-firm summary. Product testing: advocacy sponsorship, unnamed lab, NY-only products, no replication. Legal limits: "Legal limits and settlements are policy choices, not health findings", and reliance on As You Sow's account. None is boilerplate.

7. Pass Readers can verify it

   Every source has a meaningful role label (e.g. "Regulatory risk assessment (primary)", "Product testing (advocacy-commissioned)", "Litigant's account of settlement"), a full title, and a description of why it was chosen. Stable identifiers are given where they exist (IARC Volume 71; NY S4389B, 2019), and every source has an archive URL. The method steps cover claim definition (step 1), evidence that does not rest on one category (step 2), the sources reviewed (step 3), and recorded limits (step 6).

Coverage: Examined all reader-visible text: title, seoTitle, socialTitle, description, claim, answer, summary, keyPoints, context, conclusion, evidence titles/summaries/limitations, objections and responses, method steps, editorial note, image captions and alt text, and source roles, titles and descriptions. Metadata fields (dates, URLs, identifiers, changelog dates) were excluded from house-style review per the auditor's scope. No web or source text used.